382 370

Cited 0 times in

국소 진행된 직장암의 수술 전 항암 화학약물 및 방사선 병행 치료 효과

DC Field Value Language
dc.contributor.author김남규-
dc.date.accessioned2019-11-11T05:39:34Z-
dc.date.available2019-11-11T05:39:34Z-
dc.date.issued2000-
dc.identifier.issn2287-9714-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/172053-
dc.description.abstractPURPOSE: Preoperative concurrent chemoradiation for locally advanced rectal cancer can reduce tumor volume and can eliminate viable tumor cells at surgical margin (lateral or posterior margin). It also achieve a rate of high resectability, and negative margin and also have been known to be a safe treatment modality even though its fatal complication was reported as 4%. The aim of this study is to analyze its efficacy and complications after concurrent chemoradiation treatment for advanced rectal cancer. METHODS : We recruited a total thirty three patients with locally advanced rectal cancer, which were staged preoperatively as T3 or T4 and multiple enlarged lymph nodes by Transrectal Ultrasonography or pelvic Magnetic Resonance Image between march 1996 and June, 1998. 5 Fluorouracil 450 mg/m2 and leucovorin 30 mg infused intravenously during the first and fifth weeks of radiation therapy (4500~5040 cGy). Surgical resection was performed after four or six weeks after completing radiation therapy. To follow up tumor response, digital rectal examination and transrectal ultrasonography were done every two weeks. RESULTS Tumor level was distal (N=16, 48.4%), middle (N=9, 27.2%) and upper (N=8, 24.4%). mean age was fifty two years old. Overall resectability was 91%. Types of operations were abdominoperineal resection (N=10, 30.3%), Low anterior resection (N=8, 24.2), Hartmann (N=8, 24.2%), Posterior exenteration (N=2. 6.1%), Total pelvic exenteration (N=2, 6.1%), colostomy only (N=3, 9.1%). Tumor response was Complete remission (N=3,10%), Partial response (N=17, 57%), Non-response (N=10, 33%), progressive disease (N=3). Pathological status was No residual tumor (N=3, 10%), T2N1 (N=5, 16.6%), T3N0 (N=6, 20%), T4N0 (N=4, 13.3%), T2N1 (N=1, 3.3%), T3N1 (N=11, 36.6%). Downstaging status was as follows: from T3 to T0 (N=2), to T2 (N=3) and From T4 to T0 (N=1), to T2 (N=3), to T3 (N=3). Postoperative morbidity was noted in 2 patients (1 case of anastomotic leakage, 1 case of wound infection). CONCLUSIONS : Preoperative concurrent chemoradiation therapy for locally advanced rectal cancer can be performed safely and show high tumor response and resectability.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher대한대장항문학회-
dc.relation.isPartOfJournal of the Korean Society of Coloproctology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.title국소 진행된 직장암의 수술 전 항암 화학약물 및 방사선 병행 치료 효과-
dc.title.alternativePreoperative Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthor김남규-
dc.contributor.googleauthor손승국-
dc.contributor.googleauthor민진식-
dc.contributor.googleauthor성진실-
dc.contributor.googleauthor노재경-
dc.contributor.localIdA00353-
dc.relation.journalcodeJ01864-
dc.identifier.eissn2287-9722-
dc.subject.keywordRectal cancer-
dc.subject.keywordPreoperative-
dc.subject.keywordChemoradiotherapy-
dc.contributor.alternativeNameKim, Nam Kyu-
dc.contributor.affiliatedAuthor김남규-
dc.citation.volume16-
dc.citation.number2-
dc.citation.startPage93-
dc.citation.endPage98-
dc.identifier.bibliographicCitationJournal of the Korean Society of Coloproctology, Vol.16(2) : 93-98, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.